Live Breaking News & Updates on Ichnos sciences

Ichnos Sciences Welcomes Eugene Zhukovsky, PhD, as New Chief Scientific Officer

Press release content from PR Newswire. The AP news staff was not involved in its creation.

New-york , United-states , Switzerland , Eugene-zhukovsky , Cyril-konto , Head-of-communications , Prnewswire-ichnos-sciences-inc , Genentech , Ichnos-sciences , Zm-scientific , Ichnos-sciences-inc , Biomunex-pharmaceuticals

Ichnos Sciences Welcomes Eugene Zhukovsky, PhD, as New Chief Scientific Officer

/PRNewswire/ Ichnos Sciences Inc., a global biotechnology company developing innovative biologic treatments in oncology and autoimmune diseases, today.

New-york , United-states , Switzerland , Eugene-zhukovsky , Cyril-konto , Head-of-communications , Genentech , Ichnos-sciences , Zm-scientific , Ichnos-sciences-inc , Biomunex-pharmaceuticals , Corporate-affairs

Ichnos Sciences Inc.: Ichnos Sciences Welcomes Eugene Zhukovsky, PhD, as New Chief Scientific Officer

NEW YORK, March 1, 2022 /PRNewswire/ Ichnos Sciences Inc., a global biotechnology company developing innovative biologic treatments in oncology and autoimmune diseases, today announced the

New-york , United-states , Switzerland , Eugene-zhukovsky , Kostenloser-wertpapierhandel , Cyril-konto , Head-of-communications , Prnewswire-ichnos-sciences-inc , Genentech , Ichnos-sciences , Zm-scientific , Ichnos-sciences-inc

Ichnos Sciences Welcomes Eugene Zhukovsky, PhD, as New Chief Scientific Officer

NEW YORK, March 1, 2022 /PRNewswire/ Ichnos Sciences Inc., a global biotechnology company developing innovative biologic treatments in oncology.

New-york , United-states , Switzerland , Eugene-zhukovsky , Cyril-konto , Head-of-communications , Genentech , Ichnos-sciences , Zm-scientific , Ichnos-sciences-inc , Biomunex-pharmaceuticals , Corporate-affairs

ICHNOS SCIENCES ANNOUNCES FORMATION OF SCIENTIFIC ADVISORY BOARD TO INFORM RESEARCH AND DEVELOPMENT STRATEGY IN IMMUNO-ONCOLOGY

/PRNewswire/ Ichnos Sciences Inc., a global biotechnology company developing innovative multispecific antibodies for oncology, today announced the formation.

New-york , United-states , Paris , France-general- , France , Texas , Philadelphia , Pennsylvania , Russia , London , City-of , United-kingdom

ICHNOS SCIENCES ANNOUNCES FORMATION OF SCIENTIFIC ADVISORY BOARD TO INFORM RESEARCH AND DEVELOPMENT STRATEGY IN IMMUNO-ONCOLOGY

NEW YORK, Feb. 28, 2022 /PRNewswire/ Ichnos Sciences Inc., a global biotechnology company developing innovative multispecific antibodies for on.

New-york , United-states , Paris , France-general- , France , Texas , Philadelphia , Pennsylvania , Russia , London , City-of , United-kingdom

ICHNOS SCIENCES ANNOUNCES FORMATION OF SCIENTIFIC ADVISORY BOARD TO INFORM RESEARCH AND DEVELOPMENT STRATEGY IN IMMUNO-ONCOLOGY

/PRNewswire/ Ichnos Sciences Inc., a global biotechnology company developing innovative multispecific antibodies for oncology, today announced the formation.

New-york , United-states , Paris , France-general- , France , Texas , Philadelphia , Pennsylvania , Russia , London , City-of , United-kingdom

ICHNOS SCIENCES ANNOUNCES FORMATION OF SCIENTIFIC ADVISORY BOARD TO INFORM RESEARCH AND DEVELOPMENT STRATEGY IN IMMUNO-ONCOLOGY

Press release content from PR Newswire. The AP news staff was not involved in its creation.

New-york , United-states , Paris , France-general- , France , Texas , Philadelphia , Pennsylvania , Russia , London , City-of , United-kingdom

Drs. Margaret Dugan and Alessandro Riva Appointed to BeiGene Board of Directors

CAMBRIDGE, Mass. & BEIJING (BUSINESS WIRE) Feb 1, 2022

New-york , United-states , Milan , Lombardia , Italy , Cambridge , Cambridgeshire , United-kingdom , Massachusetts , New-york-university , Johnv-oyler , Margaret-dugan

Immuneering Appoints Rimma Steinhertz, Ph.D., PMP as Vice President, Project and Alliance Management

03.01.2022 - CAMBRIDGE, Mass., Jan. 03, 2022 (GLOBE NEWSWIRE) - Immuneering Corporation (Nasdaq: IMRX), a biopharmaceutical company advancing a robust pipeline of oncology and neuroscience product candidates that are designed to uniquely disrupt cellular . Seite 1

Cambridge , Cambridgeshire , United-kingdom , Ben-zeskind , Rimma-steinhertz , Alliance-management , Portfolio-program-management , Johnson-pharmaceutical-research-development , Eisai-inc , Immuneering-corporation-nasdaq , Glenmark-pharmaceuticals-ichnos-sciences-inc , Program-alliance-management